Home › Funds › CAPITAL FUND MANAGEMENT S.A. › ALNY

CAPITAL FUND MANAGEMENT S.A. position in ALNY

ALNYLAM PHARMACEUTICALS INC · Health Care

CAPITAL FUND MANAGEMENT S.A. reported holding 155,904 shares of ALNY (ALNYLAM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$46.9M, representing 0.62% of its reported portfolio and ranking #15 among its reported holdings. CAPITAL FUND MANAGEMENT S.A. has disclosed ALNY holdings in 5 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)155.90K sh
Reported value held$46.93M
Portfolio Weight0.62%
First reportedQ1 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CAPITAL FUND MANAGEMENT S.A.'s ALNY position evolved

CAPITAL FUND MANAGEMENT S.A. first disclosed a stake in ALNY in Q1 2024 at 30,367 shares (US$4.5M). The position peaked in Q2 2026 at 155,904 shares, worth US$46.9M. Across 5 filings, CAPITAL FUND MANAGEMENT S.A. increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 155,904 shares valued at US$46.9M — an increase of 15,795 shares quarter over quarter.. Notable position changes include a 38% increase in Q2 2024 (shares rose 13% over the following quarter), a 569% increase in Q1 2026 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 30.37K $4.54M New
Q2 2024 41.82K $10.16M Add
Q4 2025 20.94K $8.33M New
Q1 2026 140.11K $46.36M Add
Q2 2026 155.90K $46.93M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALNY and 13F data

ALNY (ALNYLAM PHARMACEUTICALS INC) is a Health Care company. 36 other funds we track also report a position in ALNY — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.70B), Baillie Gifford & Co (US$734.5M), Orbis Allan Gray Ltd (US$598.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALNY

All ALNY fund holders →

FAQ

How long has CAPITAL FUND MANAGEMENT S.A. held ALNY?

CAPITAL FUND MANAGEMENT S.A. has disclosed ALNY holdings in 5 of the last 10 reported quarters, going back to Q1 2024.

What is CAPITAL FUND MANAGEMENT S.A.'s current position in ALNY?

As of Q2 2026, CAPITAL FUND MANAGEMENT S.A. holds 155.90K shares of ALNY (ALNYLAM PHARMACEUTICALS INC), valued at $46.93M, representing 0.62% of its reported portfolio and ranking #15.

Has CAPITAL FUND MANAGEMENT S.A. been buying or selling ALNY?

In the latest 13F filing (Q2 2026), CAPITAL FUND MANAGEMENT S.A. increased its position in ALNY. The position peaked in Q2 2026 at 155.90K shares.

Which other funds hold ALNY?

Other major institutional holders of ALNY include T. Rowe Price Investment Management, Inc., Baillie Gifford & Co, Orbis Allan Gray Ltd, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.